FDA Adverse Event Malfunction Summary report: N

TRUEMETRIX

MDR report key: 6231083 · Received January 6, 2017

Report

Report Number
1000113657-2017-00030
Event Type
Malfunction
Date Received
January 6, 2017
Date of Event
December 13, 2016
Report Date
January 6, 2017
Manufacturer
TRIVIDIA HEALTH, INC.
Product Code
NBW
UDI-DI
00021292006075
PMA / PMN Number
K140100
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SC
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

INTERNAL REPORT # (B)(4). PRODUCT NOT YET RETURNED FOR EVALUATION. MOST LIKELY UNDERLYING ROOT CAUSE OF MALFUNCTION: USER'S TEST STRIP HAD POOR STORAGE (BATHROOM). TEST STRIP UDI# (B)(4).

Description of Event or Problem · 1

CONSUMER REPORTED COMPLAINT FOR HIGH BLOOD GLUCOSE TEST RESULTS. THE CUSTOMER IS CONCERNED WITH TESTS RESULTS FROM RESULTS OBTAINED OF 397 MG/DL. THE CUSTOMER'S EXPECTED FASTING BLOOD GLUCOSE TEST RESULT RANGE IS 120 - 140 MG/DL. THE CUSTOMER FEELS WELL AND DID NOT REPORT ANY SYMPTOMS. MEDICAL ATTENTION IS NOT REPORTED AS A RESULT OF THE ACTUAL BLOOD GLUCOSE RESULTS. DURING THE CALL ON (B)(6) 2016, A BACK TO BACK BLOOD TEST WAS PERFORMED BY THE CUSTOMER FASTING AND PRODUCED TEST RESULTS OF 150 MG/DL USING TRUEMETRIX METER AND 137 MG/DL USING TRUEMETRIX METER. THE PRODUCT IS NOT STORED ACCORDING TO SPECIFICATION AND IS STORED IN THE BATHROOM. THE TEST STRIP LOT MANUFACTURER'S EXPIRATION DATE IS 03/21/2018 AND OPEN VIAL DATE IS 12/06/2016. THE METER MEMORY WAS REVIEWED FOR PREVIOUS TEST RESULT HISTORY (DATE/TIME NOT SET): THE 147MG/DL (B)(6) 2016 07:40 AM FASTING:YES, THE 166MG/DL (B)(6) 2016 07:37 AM FASTING:YES, THE 244MG/DL (B)(6) 2016 07:36 AM FASTING:YES, THE 181MG/DL (B)(6) 2016 07:34 AM FASTING:YES, THE 397MG/DL (B)(6) 2016 07:32 AM FASTING:YES. MEMORY CONCERNS:397MG/DL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
13249 TRUEMETRIX BLOOD GLUCOSE SYSTEM NBW TRIVIDIA HEALTH, INC. TRUEMETRIX MT1976 00021292006075

Patients

Seq Age Sex Outcome Treatment
1 0 YR SECOND THERAPY